Image

Melanoma Research

Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
04/04/2019

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma”
03/20/2019

Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma

AIM at Melanoma will very soon announce the grand opening of the first branch of the International Tissue Bank Consortium…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Melanoma International Collaborative Adaptive Trials: Progress Report”
11/13/2018

Melanoma International Collaborative Adaptive Trials: Progress Report

The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “The Melanoma Tissue Bank: Progress Report”
11/13/2018

The Melanoma Tissue Bank: Progress Report

As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “Q&A With Three Leading Melanoma Specialists”
09/04/2018

Q&A With Three Leading Melanoma Specialists

Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

  Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
Blog - Melanoma360
, 
Melanoma Research
04/04/2019

AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center

April 5, 2019 (San Rafael, California)… AIM at Melanoma announces the grand opening of the first branch of the International…
Featured image for “AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
03/20/2019

Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma

AIM at Melanoma will very soon announce the grand opening of the first branch of the International Tissue Bank Consortium…
Featured image for “Why Fresh-Frozen Primary Tissue is Critically Important in the Fight Against Melanoma”
Blog - Melanoma360
 | 
Melanoma Research
11/13/2018

Melanoma International Collaborative Adaptive Trials: Progress Report

The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Featured image for “Melanoma International Collaborative Adaptive Trials: Progress Report”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/13/2018

The Melanoma Tissue Bank: Progress Report

As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
Featured image for “The Melanoma Tissue Bank: Progress Report”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
09/04/2018

Q&A With Three Leading Melanoma Specialists

Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
Featured image for “Q&A With Three Leading Melanoma Specialists”
Blog - Melanoma360
 | 
Melanoma Research
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

  Dr. Omid Hamid is recognized nationally and internationally as a key opinion leader in Immuno-Oncologic Drug Development and Melanoma…
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
Blog - Melanoma360
 | 
Melanoma Research

Recent Posts

Featured image for “Navigating Melanoma Together: 2024 Podcast Wrap-Up”
Dec. 12, 2024

Navigating Melanoma Together: 2024 Podcast Wrap-Up

Featured image for “Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel”
Dec. 10, 2024

Beyond the Clinic’s New Host: Introducing Dr. Sam Siegel

Featured image for “Managing Melanoma During the Holiday Season”
Dec. 09, 2024

Managing Melanoma During the Holiday Season

Featured image for “Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship”
Dec. 05, 2024

Beyond the Clinic’s New Host: Dr. Sam Siegel Brings a Fresh Voice to Survivorship

Featured image for “Receiving a Heart Increases Melanoma Risk”
Dec. 03, 2024

Receiving a Heart Increases Melanoma Risk

Filter by Tag